China’s Drug-Buying Growth Attracts Japanese Makers
This article was originally published in PharmAsia News
Executive Summary
China's double-digit growth in pharmaceutical purchases has sparked an interest in Japanese drug makers in expanding their own markets in the country. The Chinese market is soon to surpass Japan to become the world's second-largest, behind only the United States. Astellas Pharma also has scheduled release of one of its drugs for later this year, Eisai is adding representatives and Dainippon Sumitomo Pharma now has a Chinese subsidiary. The Japanese makers see China as a replacement for dwindling markets in the United States and the European Union as the Chinese become more affluent. (Click here for more - a subscription may be required